| 000 | 01799 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513232422.0 | ||
| 264 | 0 | _c20010315 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, L | |
| 245 | 0 | 0 |
_aInhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. _h[electronic resource] |
| 260 |
_bCancer research _cFeb 2001 |
||
| 300 |
_a1073-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAphidicolin _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGenes, Reporter _xdrug effects |
| 650 | 0 | 4 |
_aGenes, myc _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xpharmacology |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aIron _xmetabolism |
| 650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeuroblastoma _xgenetics |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogenes _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aIyer, J | |
| 700 | 1 | _aZhu, S | |
| 700 | 1 | _aFrick, K K | |
| 700 | 1 | _aWada, R K | |
| 700 | 1 | _aEskenazi, A E | |
| 700 | 1 | _aBerg, P E | |
| 700 | 1 | _aIkegaki, N | |
| 700 | 1 | _aKennett, R H | |
| 700 | 1 | _aFrantz, C N | |
| 773 | 0 |
_tCancer research _gvol. 61 _gno. 3 _gp. 1073-9 |
|
| 999 |
_c11159703 _d11159703 |
||